GLS2 and breast carcinoma: Interestingly, in luminal-subtype breast cancer cells, GLS2 expression is upregulated via GATA-binding factor 3 (GATA3) [47], indicating that its expression pattern differs not only between tissues but, also, between cancer subtypes affecting the same tissue.